Ultralife (ULBI) Research & Development (2010 - 2026)

Ultralife's Research & Development history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Research & Development rose 23.17% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 22.87% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 25.76% from the prior year.
• Research & Development climbed to $3.0 million in Q1 2026 per ULBI's latest filing, from $2.8 million in the prior quarter.
• Across five years, Research & Development topped out at $3.0 million in Q1 2026 and bottomed at $1.7 million in Q4 2022.
• The 5-year median for Research & Development is $2.0 million (2024), against an average of $2.1 million.
• Across the five-year window, Research & Development decreased 13.58% in 2024 and jumped 36.9% in 2025, its largest moves.
• Year by year, Research & Development stood at $1.7 million in 2022, then grew by 11.84% to $1.9 million in 2023, then surged by 30.35% to $2.4 million in 2024, then climbed by 16.86% to $2.8 million in 2025, then climbed by 4.96% to $3.0 million in 2026.
• Per Business Quant, the three latest ULBI Research & Development figures stand at $3.0 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025).